For advanced head and neck cancers that have stopped responding to other therapies, there may be a new treatment option that uses something you leaned about in high school science class.

A study of 222 cases of oral or oropharyngeal cancer has yielded startling results about the role of gene expression in metastasis.

According to a new report from Henry Ford Hospital in Detroit, preserving a patient's voice and rebuilding the trachea is possible after removing an invasive throat tumor.

Oral bisphosphonates, a treatment for bone disease, may double the risk of developing esophageal cancer (cancer of the gullet), according to a new study from the University of Oxford.